98%
921
2 minutes
20
Microvascular invasion (MVI) of hepatocellular carcinoma (HCC) is a crucial histopathologic prognostic factor associated with cancer recurrence after liver transplantation or hepatectomy. Recently, clinicoradiologic characteristics are combined with medical images to enhance the HCC prediction. However, compared to medical imaging data, the clinicoradiologic characteristics (e.g., APOe4 genotyping) is not easy to collect or even unavailable, as it requires more efforts of clinicians and more medical instruments for collecting diverse measurements. This work explores how to transfer the knowledge of a teacher network learned from non-image clinical data and image data to a student network with only image data such that the student network can leverage the transferred clinical information to boost HCC classification with only imaging data as input. Specifically, we present a modality-aware distillation network (MD-Net) to transform non-image clinicoradiologic from the teacher network to the student network. The teacher network integrates non-image clinicoradiologic characteristics with two 3D MRI modality images via two MRI-clinical-fusion modules and a symmetric attention (SA) module, while the student network extracts features from two modality MRI data via two MRI-only modules and then refine these two MRI features via a SA module. A classification-level distillation and a feature-level distillation are jointly utilized to transfer the clinical information between teacher and student networks. Furthermore, we design a novel self-supervised task to predict clinicoradiologic characteristics from the imaging data to further enhance the downstream HCC classification. The experimental results from our collected dataset and a multi-modal sarcasm detection dataset have demonstrated the effectiveness of our approach. Specifically, we achieved an AUC score of 71.86% and 75.51% respectively, surpassing the performance of the state-of-the-art classification methods.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/TBME.2024.3523921 | DOI Listing |
Clin Infect Dis
September 2025
Unit of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Background: Progressive Multifocal Leukoencephalopathy (PML) is a severe demyelinating disease caused by JC polyomavirus (JCV), affecting immunocompromised individuals. We describe PML demographic, clinical, radiological and laboratory characteristics and survival over time and according to underlying condition in a large retrospective patient cohort.
Methods: This is a retrospective cohort including Italian PML patients observed between 1987 and 2024, with known year of diagnosis and underlying disease.
Clin Oral Investig
September 2025
Department of Stomatology, A.C. Camargo Cancer Center, Rua Prof. Antônio Prudente, 211, Liberdade, São Paulo, 01509-900, SP, Brazil.
Objectives: The aim of this study was to evaluate the clinicoradiological features and treatment approaches of MRONJ in cancer patients rehabilitated with osseointegrated implants.
Materials And Methods: Medical records of 147 patients who developed MRONJ over a 16-year period were evaluated. Demographic data, type of antiresorptive medication (AR) used, route of administration, frequency, and time of use were collected.
Insights Imaging
August 2025
Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Objectives: To predict tertiary lymphoid structures (TLSs) in gallbladder cancer (GBC) using preoperative magnetic resonance imaging (MRI)-based radiomics.
Methods: Patients with GBC from two centres served as training (n = 129) and external validation (n = 44) cohorts. Radiomics features were extracted from six imaging sequences for inclusion in a radiomics model (Rad-score).
Lung Cancer
September 2025
National Cancer Center Research Institute, Division of Medical AI Research and Development, Tokyo 104-0045, Japan; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-Ku, Tokyo 103-0027, Japan.
Introduction: Integrated recurrence prediction models that combine clinical, imaging, and genetic data are lacking for epidermal growth factor receptor (EGFR)-mutated stage I non-small cell lung cancer (NSCLC). We developed a recurrence prediction model for Stage I EGFR-mutated NSCLC by integrating clinical, radiological, and whole-exome sequencing (WES) data.
Methods: A total of 306 patients with Stage I EGFR-mutated NSCLC were stratified into training (n = 206) and validation (n = 100) cohorts using stratified random sampling.
Mult Scler Relat Disord
August 2025
Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India. Electronic address:
Background: Double seronegative (DSN) central nervous system demyelination is heterogeneous, with limited information on therapeutic options and outcomes. Comparisons with aquaporin-4 antibody-positive (AQP4-IgG+) neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) may provide clarity.
Objective: To compare the clinico-radiological profiles, treatments, and outcomes of DSN-NMOSD with AQP4-IgG+ NMOSD and MOGAD.